Symptoms of overdose include nausea and vomiting, and withdrawal bleeding may occur in females.
Dienestrol is a synthetic, non-steroidal estrogen. It is an estrogen receptor agonist. Estrogens work partly by increasing a normal clear discharge from the vagina and making the vulva and urethra healthy. Using or applying an estrogen relieves or lessens: dryness and soreness in the vagina, itching, redness, or soreness of the vulva. Conditions that are treated with vaginal estrogens include a genital skin condition (vulvar atrophy), inflammation of the vagina (atrophic vaginitis), and inflammation of the urethra (atrophic urethritis).
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Prasterone | The risk or severity of adverse effects can be increased when Prasterone is combined with Dienestrol. |
| Exemestane | The therapeutic efficacy of Exemestane can be decreased when used in combination with Dienestrol. |
| Lenalidomide | Dienestrol may increase the thrombogenic activities of Lenalidomide. |
| Ospemifene | The risk or severity of adverse effects can be increased when Dienestrol is combined with Ospemifene. |
| Ropinirole | Dienestrol may increase the excretion rate of Ropinirole which could result in a lower serum level and potentially a reduction in efficacy. |
| Thalidomide | Dienestrol may increase the thrombogenic activities of Thalidomide. |
| Cetuximab | Dienestrol may increase the thrombogenic activities of Cetuximab. |
| Human immunoglobulin G | Dienestrol may increase the thrombogenic activities of Human immunoglobulin G. |
| Omalizumab | Dienestrol may increase the thrombogenic activities of Omalizumab. |
| Adalimumab | Dienestrol may increase the thrombogenic activities of Adalimumab. |
| Abciximab | Dienestrol may increase the thrombogenic activities of Abciximab. |
| Gemtuzumab ozogamicin | Dienestrol may increase the thrombogenic activities of Gemtuzumab ozogamicin. |
| Indium In-111 satumomab pendetide | Dienestrol may increase the thrombogenic activities of Indium In-111 satumomab pendetide. |
| Infliximab | Dienestrol may increase the thrombogenic activities of Infliximab. |
| Trastuzumab | Dienestrol may increase the thrombogenic activities of Trastuzumab. |
| Rituximab | Dienestrol may increase the thrombogenic activities of Rituximab. |
| Basiliximab | Dienestrol may increase the thrombogenic activities of Basiliximab. |
| Muromonab | Dienestrol may increase the thrombogenic activities of Muromonab. |
| Digoxin Immune Fab (Ovine) | Dienestrol may increase the thrombogenic activities of Digoxin Immune Fab (Ovine). |
| Ibritumomab tiuxetan | Dienestrol may increase the thrombogenic activities of Ibritumomab tiuxetan. |
| Tositumomab | Dienestrol may increase the thrombogenic activities of Tositumomab. |
| Alemtuzumab | Dienestrol may increase the thrombogenic activities of Alemtuzumab. |
| Capromab pendetide | Dienestrol may increase the thrombogenic activities of Capromab pendetide. |
| Efalizumab | Dienestrol may increase the thrombogenic activities of Efalizumab. |
| Antithymocyte immunoglobulin (rabbit) | Dienestrol may increase the thrombogenic activities of Antithymocyte immunoglobulin (rabbit). |
| Natalizumab | Dienestrol may increase the thrombogenic activities of Natalizumab. |
| Palivizumab | Dienestrol may increase the thrombogenic activities of Palivizumab. |
| Daclizumab | Dienestrol may increase the thrombogenic activities of Daclizumab. |
| Bevacizumab | Dienestrol may increase the thrombogenic activities of Bevacizumab. |
| Technetium Tc-99m arcitumomab | Dienestrol may increase the thrombogenic activities of Technetium Tc-99m arcitumomab. |
| Eculizumab | Dienestrol may increase the thrombogenic activities of Eculizumab. |
| Panitumumab | Dienestrol may increase the thrombogenic activities of Panitumumab. |
| Ranibizumab | Dienestrol may increase the thrombogenic activities of Ranibizumab. |
| Galiximab | Dienestrol may increase the thrombogenic activities of Galiximab. |
| Pexelizumab | Dienestrol may increase the thrombogenic activities of Pexelizumab. |
| Afelimomab | Dienestrol may increase the thrombogenic activities of Afelimomab. |
| Epratuzumab | Dienestrol may increase the thrombogenic activities of Epratuzumab. |
| Bectumomab | Dienestrol may increase the thrombogenic activities of Bectumomab. |
| Oregovomab | Dienestrol may increase the thrombogenic activities of Oregovomab. |
| IGN311 | Dienestrol may increase the thrombogenic activities of IGN311. |
| Adecatumumab | Dienestrol may increase the thrombogenic activities of Adecatumumab. |
| Labetuzumab | Dienestrol may increase the thrombogenic activities of Labetuzumab. |
| Matuzumab | Dienestrol may increase the thrombogenic activities of Matuzumab. |
| Fontolizumab | Dienestrol may increase the thrombogenic activities of Fontolizumab. |
| Bavituximab | Dienestrol may increase the thrombogenic activities of Bavituximab. |
| CR002 | Dienestrol may increase the thrombogenic activities of CR002. |
| Rozrolimupab | Dienestrol may increase the thrombogenic activities of Rozrolimupab. |
| Girentuximab | Dienestrol may increase the thrombogenic activities of Girentuximab. |
| Obiltoxaximab | Dienestrol may increase the thrombogenic activities of Obiltoxaximab. |
| XTL-001 | Dienestrol may increase the thrombogenic activities of XTL-001. |
| NAV 1800 | Dienestrol may increase the thrombogenic activities of NAV 1800. |
| Briakinumab | Dienestrol may increase the thrombogenic activities of Briakinumab. |
| Otelixizumab | Dienestrol may increase the thrombogenic activities of Otelixizumab. |
| AMG 108 | Dienestrol may increase the thrombogenic activities of AMG 108. |
| Iratumumab | Dienestrol may increase the thrombogenic activities of Iratumumab. |
| Enokizumab | Dienestrol may increase the thrombogenic activities of Enokizumab. |
| Ramucirumab | Dienestrol may increase the thrombogenic activities of Ramucirumab. |
| Farletuzumab | Dienestrol may increase the thrombogenic activities of Farletuzumab. |
| Veltuzumab | Dienestrol may increase the thrombogenic activities of Veltuzumab. |
| Ustekinumab | Dienestrol may increase the thrombogenic activities of Ustekinumab. |
| Trastuzumab emtansine | Dienestrol may increase the thrombogenic activities of Trastuzumab emtansine. |
| PRO-542 | Dienestrol may increase the thrombogenic activities of PRO-542. |
| TNX-901 | Dienestrol may increase the thrombogenic activities of TNX-901. |
| Inotuzumab ozogamicin | Dienestrol may increase the thrombogenic activities of Inotuzumab ozogamicin. |
| RI 624 | Dienestrol may increase the thrombogenic activities of RI 624. |
| Stamulumab | Dienestrol may increase the thrombogenic activities of MYO-029. |
| CT-011 | Dienestrol may increase the thrombogenic activities of CT-011. |
| Leronlimab | Dienestrol may increase the thrombogenic activities of Leronlimab. |
| Glembatumumab vedotin | Dienestrol may increase the thrombogenic activities of Glembatumumab vedotin. |
| Olaratumab | Dienestrol may increase the thrombogenic activities of Olaratumab. |
| IPH 2101 | Dienestrol may increase the thrombogenic activities of IPH 2101. |
| TB-402 | Dienestrol may increase the thrombogenic activities of TB-402. |
| Caplacizumab | Dienestrol may increase the thrombogenic activities of Caplacizumab. |
| IMC-1C11 | Dienestrol may increase the thrombogenic activities of IMC-1C11. |
| Eldelumab | Dienestrol may increase the thrombogenic activities of Eldelumab. |
| Lumiliximab | Dienestrol may increase the thrombogenic activities of Lumiliximab. |
| Canakinumab | Dienestrol may increase the thrombogenic activities of Canakinumab. |
| Ipilimumab | Dienestrol may increase the thrombogenic activities of Ipilimumab. |
| Nimotuzumab | Dienestrol may increase the thrombogenic activities of Nimotuzumab. |
| Clenoliximab | Dienestrol may increase the thrombogenic activities of Clenoliximab. |
| Tocilizumab | Dienestrol may increase the thrombogenic activities of Tocilizumab. |
| BIIB015 | Dienestrol may increase the thrombogenic activities of BIIB015. |
| Sonepcizumab | Dienestrol may increase the thrombogenic activities of Sonepcizumab. |
| Motavizumab | Dienestrol may increase the thrombogenic activities of Motavizumab. |
| Elotuzumab | Dienestrol may increase the thrombogenic activities of Elotuzumab. |
| AVE9633 | Dienestrol may increase the thrombogenic activities of AVE9633. |
| Carotuximab | Dienestrol may increase the thrombogenic activities of Carotuximab. |
| XmAb 2513 | Dienestrol may increase the thrombogenic activities of XmAb 2513. |
| Coltuximab ravtansine | Dienestrol may increase the thrombogenic activities of Coltuximab ravtansine. |
| Lucatumumab | Dienestrol may increase the thrombogenic activities of Lucatumumab. |
| Pertuzumab | Dienestrol may increase the thrombogenic activities of Pertuzumab. |
| Siplizumab | Dienestrol may increase the thrombogenic activities of Siplizumab. |
| Apolizumab | Dienestrol may increase the thrombogenic activities of Apolizumab. |
| Sibrotuzumab | Dienestrol may increase the thrombogenic activities of Sibrotuzumab. |
| Bivatuzumab | Dienestrol may increase the thrombogenic activities of Bivatuzumab. |
| Lerdelimumab | Dienestrol may increase the thrombogenic activities of Lerdelimumab. |
| Lexatumumab | Dienestrol may increase the thrombogenic activities of Lexatumumab. |
| Reslizumab | Dienestrol may increase the thrombogenic activities of Reslizumab. |
| Teplizumab | Dienestrol may increase the thrombogenic activities of Teplizumab. |
| Catumaxomab | Dienestrol may increase the thrombogenic activities of Catumaxomab. |